Metabolic syndrome related to cardiovascular events in a 10-year prospective study

Diabetology and Metabolic Syndrome

Volumn 7, Issue 1, 2015, Pages

  Kazlauskiene, Laura ^a   Butnoriene, Ju¯rate ^a   Norkus, Antanas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Cardiovascular events; Metabolic syndrome; Metabolic syndrome components

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; CARDIOLOGIST; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPERTRIGLYCERIDEMIA; LITHUANIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEUROLOGIST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 84947781820     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/s13098-015-0096-2     Document Type: Article

References (34)

1. Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
2. Espinola-Klein Ch, Rupprecht J, Bickel Ch, Post F, Genth-Zotz S, Lackner K, et al., for the AtherGene Investigators. Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. Am J Cardiol 2007;99:1623-8.
3. Suh Sungwan, Baek Jongha, Ji Cheol Bae, Kyoung-Nyoun Kim, Mi Kyoung Park, Duk Kyu Kim, Nam H Cho, Moon-Kyu Lee. Sex factors in the metabolic syndrome as a predictor of cardiovascular disease. Endocrinol Metabol. 2014;29(4):522-9.
4. Gimeno Orna JA, Lou Arnal LM, Molinero Herguedas E, Boned Julian B, Portilla Cordoba, DP. Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes. Rev Esp Cardiol. 2004;57(6):507-13.
5. Tonstad S, Hjermann I. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year old men and women. J Cardiovasc Risk. 2003;10:129-35.
6. European Guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prevent Rehabil. 2003; 10 (Suppl 1): S1-S78.
7. Alexander CM, Landsman PB, Teutsch SM. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol. 2000;86:897-902.
8. Kreisberg RA. Hypertriglyceridemia and coronary heart disease. Clin Rev Spring. 2000; 29-32.
9. Young KL, Allen JK, Kelly KM. HDL cholesterol: striving for healthier levels. Clin Rev. 2001;11(5):50-61.
10. Isomaa B, Almgren P, Tuomi T, Forden B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683-9.
11. Klein BEK, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver DAM. Diab Care. 2002;25:1790-4.
12. Nakaniski N, Takatorige T, Fukuda H, Shirai K, Li W, Okamoto, et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract. 2004;64:59-70.
13. Černiauskiene LR, Lukšiene DI, Reklaitiene R, Margevičiene L. The relationship of ischemic heart disease with number of components of metabolic syndrome among middle-aged Kaunas population. Medicinos teorija ir praktika. 2006;2(46):32-8.
14. Mancia G, Backer G, Dominiczak A, Cifkova R, Fegard R, Germano G, Grassi G, Heagerty a. M, Laurent S et al. Management of Arterial Hypertension of the European Society of Hypertension; European of Cardiology. 2007 structure and function in hypertensive men and women. Hypertension. 2006; 47:881-886.
15. European Atherosclerosis Society Study Group. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J. 1987;8:77-88.
16. Friedewald WT, Levy RI, Fredricson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
17. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5.
18. Lee HY, Byung-Hee Oh. Ageing and Arterial Stiffness. Circ J. 2010;74:2257-62.
19. Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 2003;108:1523-7.
20. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005;109:143-59.
21. Wakabayashi I, Masuda H. Association of acuta-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta. 2006;365:230-5.
22. Hassinen M, Komulainen P, Lakka TA, Vaisanen SB, Haapala I, Gylling H, et al. Metabolic syndrome and the progression of carotid intima-media thickness in elderly women. Arch Intern Med. 2006;166:444-9.
23. Kawamoto R, Tomita H, Inoue A, Ohtsuka N, Kamitani A. Metabolic syndrome may be risk factor for early carotid atherosclerosis in women but not in men. J Atheroscler Thromb. 2007;14:36-43.
24. Tsuda K. Sex hormones and carotid atherosclerosis in the metabolic syndrome (Letter). Stroke. 2005;36:2528.
25. Rodriguez A, Muller DC, Metter EJ, Maggio M, Harman SM, Blackman MR, Andres R. Ageing, androgens and the metabolic syndrome in a longitudinal study of ageing. J Clin Endocrinol Metab. 2007;92:3568-72.
26. Empana JP, Zureik M, Gariepy J, Courbon D, Dartigues JF, Ritchie K, et al. The metabolic syndrome and the carotid artery structure in non institutionalized elderly subjects: the three-city study. Stroke. 2007;38:893-9.
27. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113-32.
28. Stevens J, Cai J, Pamuk ER, et al. Chronic sub clinical inflammation as part of insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study RAS). Circulation. 2000;102:42-7.
29. Lapidus L, Bengtsson C, Larsson B, et al. Distribution of adipose tissue and risk of cardiovascular disease band death: 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. BMJ (Clin Res Ed). 1984;289:1257-61.
30. Geis LS, Herman WH, Smith PJ. For the National Diabetes Data Group. Diabetes in America, 2nd edn. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease. 1995. NIH Publication No. 95-1468.
31. Alexander ChM, Landsman PB, Grundy SM. Metabolic syndrome and hyperglycaemia: congruence and divergence. Available from: URL: http://www.AJConline.org.
32. Tong PC, Kong AP, So W-Y, Yang X, Ho Ch-Sh, Ma RC, et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult treatment panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care. 2007;30:1206-11.
33. Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S, Baraldi L, et al. WHO and ATPIII proposals for definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med. 2004;21(4):383.
34. Žaliu¯nas R, Šlapikas R, Lukšiene D, Šlapikiene B. Prevalence of metabolic syndrome components in patients with acute coronary syndromes. Medicina. 2008;44(3):182-8.